Home » Topics » BioWorld

BioWorld
RSS

FDA TO REVIEW CHIRON, CYTOGEN PRODUCTS

Dec. 23, 1991

COURT SMOTHERS NICODERM INJUNCTION

Dec. 23, 1991

BTGC GROSSES $13 MILLION IN STOCK SALE

Dec. 23, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 23, 1991

DYNAGEN LICENSES TB ANTIBODIES

Dec. 23, 1991

CHIEF SCIENTIFIC OFFICER LEAVES LIDAK

Dec. 23, 1991

AMGEN FILES SHELF REGISTRATION

Dec. 20, 1991

TWO COMPANIES CHANGE NAMES

Dec. 20, 1991

LIPOSOMAL CLOT-BUSTERS MAY CUT COSTS

Dec. 20, 1991

NICOTINE PATCH MOTION WITHDRAWN

Dec. 20, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.